E-viri
Recenzirano
Odprti dostop
-
CAPPELLARI, Manuel; BOVI, Paolo; TASSINARI, Tiziana; PROCACCIANTI, Gaetano; DI LAZZARO, Vincenzo; BETTONI, Luigi; GANDOLFO, Carlo; SILVESTRELLI, Giorgio; RASURA, Maurizia; MARTINI, Giuseppe; MELIS, Maurizio; VITTORIA CALLONI, Maria; MORETTO, Giuseppe; CHIODO-GRANDI, Fabio; BERETTA, Simone; GUARINO, Maria; CONCETTA ALTAVISTA, Maria; MARCHESELLI, Simona; GALLETTI, Giampiero; ADOBBATI, Laura; DEL SETTE, Massimo; MANCINI, Armando; ORRICO, Daniele; ZINI, Andrea; MONACO, Serena; CAVALLINI, Anna; SCIOLLA, Rossella; FEDERICO, Francesco; SCODITTI, Umberto; BRUSAFERRI, Fabio; GRASSA, Claudio; SPECCHIO, Luigi; ROBERTA BONGIOANNI, Maria; SPARACO, Marco; NENCINI, Patrizia; ZAMPOLINI, Mauro; GRECO, Gabriele; COLOMBO, Rinaldo; PASSARELLA, Bruno; ADAMI, Alessandro; CONSOLI, Domenico; TONI, Danilo; SESSA, Maria; FURLAN, Mauro; PEZZINI, Alessandro; ORLANDI, Giovanni; PACIARONI, Maurizio
Neurology, 02/2013, Letnik: 80, Številka: 7Journal Article
To assess the impact on stroke outcome of statin use in the acute phase after IV thrombolysis. Multicenter study on prospectively collected data of 2,072 stroke patients treated with IV thrombolysis. Outcome measures of efficacy were neurologic improvement (NIH Stroke Scale NIHSS ≤ 4 points from baseline or NIHSS = 0) and major neurologic improvement (NIHSS ≤ 8 points from baseline or NIHSS = 0) at 7 days and favorable (modified Rankin Scale mRS ≤ 2) and excellent functional outcome (mRS ≤ 1) at 3 months. Outcome measures of safety were 7-day neurologic deterioration (NIHSS ≥ 4 points from baseline or death), symptomatic intracerebral hemorrhage type 2 with NIHSS ≥ 4 points from baseline or death within 36 hours, and 3-month death. Adjusted multivariate analysis showed that statin use in the acute phase was associated with neurologic improvement (odds ratio OR 1.68, 95% confidence interval CI 1.26-2.25; p < 0.001), major neurologic improvement (OR 1.43, 95% CI 1.11-1.85; p = 0.006), favorable functional outcome (OR 1.63, 95% CI 1.18-2.26; p = 0.003), and a reduced risk of neurologic deterioration (OR: 0.31, 95% CI 0.19-0.53; p < 0.001) and death (OR 0.48, 95% CI 0.28-0.82; p = 0.007). Statin use in the acute phase of stroke after IV thrombolysis may positively influence short- and long-term outcome.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.